ArticleFrontiers in oncology2019

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.

Yixing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.